Corrigendum to “Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung”

In the article titled “Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung” [1], the authors identified an error in the name of the manufacturer of the antibody mentioned in Materials and Methods. The following should be corrected from

“LAMP2A (Novus Biologicals, Zug, Switzerland, rabbit polyclonal, #NB600-1384)

HSC70 (LabForcembl, Nunningen, Switzerland, rabbit polyclonal, #PM0045)”

to

“LAMP2A (Abcam, Cambridge, UK, rabbit polyclonal, ab18528)

HSC70 (Thermo Fisher Scientific, Waltham, MA, USA, mouse monoclonal, MA3-014)”